The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
Open accessAbstract
Recent studies have established a new regulatory axis in the renin-angiotensin system (RAS). In this axis, angiotensin (Ang)-(1-7) is finally produced from Ang I or Ang II by the catalytic activity of angiotensin-converting enzyme 2 (ACE2). Ang-(1-7) shows actions different from those of AT(1) receptor stimulation, such as vasodilatation, natriuresis, anti-proliferation and an increase in the bradykinin-NO (nitric oxide) system. As the catalytic efficiency of ACE2 is approximately 400-fold higher with Ang II as a substrate than with Ang I, this axis is possibly acting as a counter-regulatory system against the ACE/Ang II/AT(1) receptor axis. The signaling pathway of the ACE2-Ang-(1-7) axis has not yet been totally and clearly understood. However, a recent report suggests that the Mas oncogene acts as a receptor for Ang-(1-7). Intracellular signaling through Mas is not clear yet. Several factors such as Akt phosphorylation, protein kinase C activation and mitogen-activated protein (MAP) kinase inhibition seem to be involved in this signaling pathway. Further investigations are needed to clarify the regulation and mechanism of action of ACE2 and Ang-(1-7). However, this second axis through ACE2 and Ang-(1-7) in RAS can be an important target for the therapy of cardiovascular and metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ACE2 on endothelial cells of the arteries, arterioles, and venules of the heart and kidney determines its ability to regulate vascular function and blood pressure, as reviewed previously.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Marc De Gasparo, B., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,131
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., Silva, A. C. S. E., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer‐Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bäder, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,805
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,250
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
Elliott, W. J., & Meyer, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60108-1 · Cited by 1,016
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Disruption of the Ang II type 1 receptor promotes longevity in mice
Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36703 · Cited by 486
Flagged first, then by citations
Research works printed but not linked: 1
- Santos RA, Ferreira AJ, E Silva AC . Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93: 519–527. · DOI
Cited by
Sorted by citations
Items 201–296 of 296
The renin–angiotensin system (RAS) and arthritic diseases: therapeutic potential for RAS inhibitors
Habib, Y. H., Khattab, M. M., & Gowayed, M. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01890-z · Cited by 6
Xu, L., Hu, G., Qiu, J., Miura, T., Yamakoshi, S., Namai-Takahashi, A., Kohzuki, M., & ITO, O. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003100 · Cited by 7
Sakuyama, A., Ogawa, Y., Xu, L.-S., Komatsu, M., Miura, T., Namai-Takahashi, A., Kohzuki, M., & Ito, O. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002901 · Cited by 4
Do angiotensin II type 1 receptor blockers have molecular effects?
Miura, S.-I., & Saku, K. (2009) · Hypertension Research · doi:10.1038/hr.2009.202 · Cited by 6
Pernomian, L., Gomes, M. S., Pernomian, L., Moreira, R. P., Corrêa, F. M. D. A., & de Oliveira, A. M. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.01.001 · Cited by 6
Olszanecki, R., Suski, M., Gębska, A., Toton-Zuranska, J., Kus, K., Madej, J., Bujak-Giżycka, B., Jawień, J., & Korbut, R. (2013) · PubMed · Cited by 6
Liu, Q., Lu, D., Wang, S., Wang, K., Zhang, Q., Wang, Y., Ping, F., Li, Z., Geng, J., & Shan, Q. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.05.006 · Cited by 6
Yang, Y., Liang, J., Zhao, C., Chen, Y., Gu, S., Yang, X., Liu, H., Qin, Q., Wang, H., Yang, Z., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.021 · Cited by 6
Exercise perspective on common cardiac medications
Dizon, L. A., Seo, D. Y., Kim, H. K., Kim, N., Ko, K. S., Rhee, B. D., & Han, J. (2013) · Integrative Medicine Research · doi:10.1016/j.imr.2013.04.006 · Cited by 6
Tiwari, P., Elgazzaz, M., Lazartigues, E. D., & Hanif, K. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112654 · Cited by 5
Li, X., & Qu, S. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05196-6 · Cited by 5
The rise of dehydrated ginsenosides: phytochemistry and pharmacology
Wang, K., Liu, J., Ma, L., Zhang, F., & Wan, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.051 · Cited by 6
Ang-(1–7) protects skeletal muscle function in aged mice
Li, Y., Song, J., Jiang, Y., Yang, X., Cao, L., Xiao, C. Y., Li, S., Dong, B., & Huang, X. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04693-9 · Cited by 6
Evaluation of Serum Levels of Renin Angiotensin System Components in Asthmatic Patients
Ayada, C., Toru, Ü., Genç, O., Şahın, S., Bulut, İ., Arık, Ö., & Acat, M. (2015) · Journal of Clinical Practice and Research · doi:10.5152/etd.2015.0027 · Cited by 5
Singh, S., Moodley, J., Khaliq, O. P., & Naicker, T. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01158-1 · Cited by 5
Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia
Amini, P., Amrovani, M., Nassaj, Z. S., Ajorlou, P., Pezeshgi, A., & Ghahrodizadehabyaneh, B. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09734-w · Cited by 5
Gestational Protein Restriction Increases Angiotensin II Production in Rat Lung1
Gao, H., Yallampalli, U., & Yallampalli, C. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.103770 · Cited by 5
Computational design of metalloproteases
Chen, A., Wu, K., Choi, H., Venkatesh, P., Pellock, S. J., Hanikel, N., Shin, H., Evans, D., Didi, K., Schaaf, L. L., et al. (2026) · Nature · doi:10.1101/2025.11.20.689622 · Cited by 4
Bakalkin, G. Y., Kahle, A., Sarkisyan, D., Watanabe, H., Lukoyanov, N., Carvalho, L. S., Galatenko, V., Hallberg, M., & Nosova, O. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15360 · Cited by 4
Tolossa, T., Lema, M., Wakuma, B., Turi, E., Fekadu, G., Mulisa, D., & Fetensa, G. (2022) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2022.2144016 · Cited by 4
Adverse Cardiac Effects of SARS-CoV-2 Infection
Göbölös, L., Manla, Y., Rácz, I., Hogan, M. P., Remsey-Semmelweis, E., Atallah, B., Aljabery, Y., Almahmeed, W. A., Alsindi, F., Bader, F. M., et al. (2022) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2022.04 · Cited by 4
Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets
Kamel, N. A., Wakeel, L. M. E., & Aboshanab, K. M. (2021) · Viral Immunology · doi:10.1089/vim.2021.0023 · Cited by 4
Kostyunin, A. E., Ovcharenko, E. A., & Барбараш, О. Л. (2019) · Kardiologiia · doi:10.18087/cardio.n328 · Cited by 4
Tang, J., Chung, W. Y., Pulente, S. M., Lei, Y., Nguyen, K., Tam, E., Morrow, N. M., Lorenzen‐Schmidt, I., Xiao, F., Zani, A., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505837 · Cited by 4
Lactation Leads to Modifications in Maternal Renin-Angiotensin System in Later Life
Rosa, M. L., Kechichian, T. B., Olson, G., Saade, G. R., & Bytautiene, E. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00018-3 · Cited by 3
Experimental Study on the Mechanism of Cinnamaldehyde Ameliorate Proteinuria Induced by Adriamycin
He, D., Li, Q., Du, G., Chen, S., & Zeng, P. (2022) · BioMed Research International · doi:10.1155/2022/9600450 · Cited by 3
Prehypertension and the Renin-Angiotensin-Aldosterone System
Kaschina, E., & Unger, T. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_22 · Cited by 3
Pagadala, N. S., Landi, A., Maturu, P., & Tuszyński, J. A. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130534 · Cited by 3
Araújo, W. F., Naves, M. A., Ravanini, J. N., & Teixeira, V. D. C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu325.8 · Cited by 3
Foulquier, S., Paulis, L., Kaschina, E., Namsolleck, P., & Unger, T. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_7 · Cited by 3
Discovery and Development of Prolylcarboxypeptidase Inhibitors for Cardiometabolic Disorders
Scarry, S. C., & Rimoldi, J. M. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00007-7 · Cited by 3
To Curb the Progression of Fatal COVID-19 Course—Dream or Reality
Price, S., Targoński, R., Sadowski, J., & Targoński, R. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01130-z · Cited by 3
Niu, Q., Wang, T., Li, J., Zhao, L., & Cai, J. (2026) · The FASEB Journal · doi:10.1096/fj.202502446r · Cited by 2
Yu, Y., Babendreyer, A., Pabst, A., Michely, A., Tauscher, M., Martin, C., Kühnel, M. P., Jonigk, D. D., Düsterhöft, S., & Ludwig, A. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120112 · Cited by 2
Singh, G., Maparu, K., & Aran, K. R. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01780-x · Cited by 2
Zhu, H., Wang, H., Zhu, X., Chen, Q., Fang, X., Xu, X., Ping, Y., Gao, B., Tong, G., Ding, Y., et al. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02343-7 · Cited by 2
Jema, J. P., Pradhan, J., Chainy, G. B. N., Hati, A. K., Nayak, D., Kaushik, S., & Dandapat, J. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100745 · Cited by 3
Liu, Y., Li, L., Wang, Z., & Yang, L. (2023) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9637 · Cited by 2
Lin, Y., Dong, S., Liu, Y., Wang, Y., Sun, X., Yuan, J., Yu, D., & Liu, H. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001325 · Cited by 2
Gene Therapy for Diabetic Retinopathy – Targeting the Renin-Angiotensin System
Li, Q., Verma, A., Zhu, P., Lei, B., Qiu, Y., Nakagawa, T., Mohan, K., & William, W. (2013) · InTech eBooks · doi:10.5772/52702 · Cited by 2
Rat Ace allele variation determines susceptibility to AngII-induced renal damage
Kamilić, J., Hamming, I., Lely, A. T., Korstanje, R., Schulze, U., Poppinga, W. J., Turner, A. J., Clarke, N. E., van Goor, H., & Navis, G. J. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320311415886 · Cited by 2
Manzel, A., Domenig, O., Ambrosius, B., Kovacs, A., Stegbauer, J., Poglitsch, M., Mueller, D. N., Gold, R., & Linker, R. A. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9548-y · Cited by 2
New Drugs Under Development for Cardiovascular Prevention
Laurent, S., & Steckelings, U. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00030-2 · Cited by 2
Barrett, M., Daowd, A., Abidi, S. S. R., & Abidi, S. (2021) · Studies in health technology and informatics · doi:10.3233/shti210187 · Cited by 2
Current Challenges for the Effective Management of the COVID-19 Pandemic
Sinha, V., Saxena, S., Pandey, S., Dwivedi, S., Thakur, S., Asea, A. A. A., Dixit, A. K., Dixit, V., Vishvakarma, N. K., & Shukla, D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-85113-2_8 · Cited by 2
Montezano, A. C. I., Cat, A. N. D., & Touyz, R. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801364-9.00023-7 · Cited by 2
Novel aspects of the renin-angiotensin system for pulmonary arterial hypertension
Tanrıverdi, L. H. (2023) · Hypertension Research · doi:10.1038/s41440-023-01211-3 · Cited by 2
Current Research of the Renin-Angiotensin System Effect on Stem Cell Therapy
Ahmadian, E., Eftekhari, A., & Khosroushahi, A. Y. (2017) · InTech eBooks · doi:10.5772/67726 · Cited by 1
Yaşar, E., Yaşar, M. M., Doğru, S., Yaraş, N., & Eroğlu, E. (2023) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s273741652350031x · Cited by 1
Dabaghi, G. G., Rad, M. R., Amani‐Beni, R., & Darouei, B. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100416 · Cited by 1
Yurtseven, A., Atık, T., Durmuşalioğlu, E. A., Turan, C., Güngör, T. K., Akarca, F. K., & Saz, E. U. (2024) · Journal of Immunology and Clinical Microbiology · doi:10.58854/jicm.1562940 · Cited by 1
Schnaubelt, S., Jakobljevich, A., Brock, R., Oppenauer, J., Kornfehl, A., Eibensteiner, F., Veigl, C., Perkmann, T., Haslacher, H., Straßl, R. P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072233 · Cited by 1
Angiotensin 1–7 Modulates the Dynamics and Activation of the Proto‐Oncogene Mas Receptor
Yasar, E., Dogru, S., Eroglu, E., & Yaras, N. (2026) · Journal of Molecular Recognition · doi:10.1002/jmr.70031 · Cited by 1
Moya, J., Novoa, U., Godoy, I. E., Chiong, M., Lavandero, S., Milad, J. J., & Ocaranza, M. P. (2012) · Revista chilena de cardiología · doi:10.4067/s0718-85602012000300004 · Cited by 1
The Renin-Angiotensin System and Cancer
Koh, S. P., Kilmister, E. J., Wickremesekera, A., Munro, M. J., Gray, C., & Tan, S. T. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-23621-1_15 · Cited by 1
Moya, J., Novoa, U., Escudero, N., Godoy, I. E., Chiong, M., Lavandero, S., Jalil, J., & Ocaranza, M. P. (2012) · Revista chilena de cardiología · doi:10.4067/s0718-85602012000200006 · Cited by 1
Sex and salt intake dependent renin-angiotensin plasticity in the liver of the rat
Pidíková, P., Svitok, P., & Herichová, I. (2019) · Endocrine Regulations · doi:10.2478/enr-2019-0018 · Cited by 1
Wilson, T. E., Mulye, M., & Akbar, S. (2020) · AJP Advances in Physiology Education · doi:10.1152/advan.00113.2020 · Cited by 1
Papageorgiou, L., Papakonstantinou, E., Diakou, I., Pierouli, K., Dragoumani, K., Bacopoulou, F., Chrousos, G. P., Eliopoulos, E., & Vlachakis, D. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31978-5_6 · Cited by 1
Renin Angiotensin System Polymorphisms and Pregnancy Complications
Zhou, A. (2012) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Batista, K. F. (2012) · Americanae (AECID Library)
Angiotensin Converting Enzyme I/D Polymorphism and Cardiovascular Risk: Disclosed Story
Vašků, A., Blahák, J., Baumgartner, D., & Vašků, J. B. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7207-1_13
Thibodeau, J.-F. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4192
da Silva, R. R., Talvani, A., Bahia, M. T., & Preto, O. (2010)
Angiotensin II during Experimentally Simulated Central Hypovolemia
Jensen, T. W., & Olsen, N. V. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00006
ASPECTOS FUNCIONAIS E FISIOLÓGICOS DO SISTEMA RENINA-ANGIOTENSINA ALDOSTERONA
Fernandes, D. R., Filho, R. D. C., Nunes, J. D. S., Geron, V. L. M. G., & Júnior, A. T. T. (2016) · Revista Científica FAEMA · doi:10.31072/rcf.v7i1.363
Targeting obesity-related inflammation through nutritional and genetic approaches
LeMieux, M. J. (2015) · ThinkTech (Texas Tech University)
Insulin Treatment Attenuates Renal ADAM17 and ACE2 Shedding in Akita Diabetic Mice
Salem, E., Grobe, N., & Elased, K. M. (2013) · Journal of Bioresource Management
Modifiers of the Kidney Response to Activation of the Renin-Angiotensin System: ACE2 and Adiponectin
Fang, F. (2014) · TSpace (University of Toronto)
Aghazadeh‐Habashi, A. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3kp7v04z
Bodellini, M. (2009) · Diritto dell'economia
Signature Analysis of EMG by Wavelet Packet after TNFR Surgery in Rat Model
Zhang, Z., Li, Y., Wang, P., Li, Y., Jiang, Z., & Yang, L. (2022) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2021.00036
Xu, C. (2022) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2022.00036
Barrett, M. J., Abidi, S. S. R., Daowd, A., & Abidi, S. (2022) · Studies in health technology and informatics · doi:10.3233/shti220084
Mohammadi, M., Rahimi, A., Salehi-Vaziri, ., Sharifnia, F., Mehrjerdi, E. K., & Karimipoor, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2048684/v1
KIM, Y. T., Nguyen, T. T., Duong, D. N., Nguyen, T. T. N., & Tran, H. V. (2022) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v6i4.1169
Mathew, C. G. (2023) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2023.111019
Morphological aspect of the angiotensin-converting enzyme 2
Yoshimura, K., Okada, Y., Toya, S., Asami, T., & Iwasaki, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99618-1.00008-8
Забежинский, М. М., & Semenova, A. A. (2023) · Pediatrician (St Petersburg) · doi:10.17816/ped14198-118
Maneshian, M., Farkhad, N. K., & Shahraki, S. (2023) · Journal of Clinical Research in Paramedical Sciences · doi:10.5812/jcrps-139751
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch3
Guo, X., Hongyu, M., Cui, Z., Zhao, Q., Zhang, Y., Jia, L., Zhang, L., Guo, H., Zhang, X., Zhang, Y., et al. (2024) · High Altitude Medicine & Biology · doi:10.1089/ham.2023.0098
The Study of the COVID-19 Virus: A Review
Forsythe, M. L. (2024) · The Open COVID Journal · doi:10.2174/0126669587296962240521114748
Li, J., Liu, Y., Liu, X., Xu, L., & Liu, Y. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.11.19
Serum Ang 1, Ang 1–7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome
Çil, G., Araz, Ö., Kerget, B., Laloğlu, E., Aksakal, A., Uçar, E. Y., & Sağlam, L. (2025) · Biomarkers in Medicine · doi:10.1080/17520363.2025.2525059
Microvascular Dysfunction Related to COVID-19 and Systemic Inflammation
Lapi, D., Chiurazzi, M., Muscariello, E., & Colantuoni, A. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_14
Pedoto, A., Gil, J. M. L., Ocaña‐Esparza, M., Conesa‐Hernández, A. M., Candel, S., Cayuela, M. J., Mulero, V., & Tyrkalska, S. D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1667880
Espósito, L. M. B., Amin, M., Varsani, R., Leite, D. M. C., Ferraresi, C., & Arany, P. R. (2026) · Journal of Photochemistry and Photobiology · doi:10.1016/j.jpap.2026.100308
Yi, X., Chu, S., Zhang, H., Tan, W., Yang, H., Song, S., Xie, J., Xu, C., & Yu, J. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026161
Mechanism underlying the anticontractile effect of perivascular adipose tissue
Dong, Y. (2014) · Research Explorer (The University of Manchester)
Metadata
- Authors
- Iwai, M., & Horiuchi, M.
- Affiliations
- Ehime University (JP)
- Corresponding author
- Horiuchi, Masatsugu
- Venue
- Hypertension Research
- Published
- 2009-05-22
- Volume
- 32
- Issue
- 7
- Pages
- 533-536
- ISSN
- 0916-9636 (ISSN-L)
- 1348-4214
- PMC
- PMC7091931
- OpenAlex
- W2067142583
- Cited by
- 296
- References
- 37
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 11 · 2023: 20 · 2022: 21 · 2021: 29 · 2020: 29 · 2019: 12 · 2018: 14 · 2017: 10 · 2016: 17 · 2015: 27 · 2014: 19 · 2013: 19 · 2012: 23
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Hypertension Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- renin-angiotensin system, angiotensin-(1-7), angiotensin-converting enzyme 2, Mas receptor, angiotensin II type 1 receptor, angiotensin II, vasodilation, sodium excretion, Akt phosphorylation, protein kinase C, MAP kinase inhibition, cardiovascular disease treatment
- MeSH terms
- Angiotensin-Converting Enzyme 2, Proto-Oncogene Mas, Angiotensin I, Animals, Humans, Peptidyl-Dipeptidase A, Peptide Fragments, Proto-Oncogene Proteins, Renin-Angiotensin System, Signal Transduction, Receptors, G-Protein-Coupled, Receptor, Angiotensin, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
